Articles

Videos

Podcasts

Clinical

Intravenous immunoglobulin shows promise as a treatment option for pregnant patients with SARS-CoV-2, influenza, and other respiratory viruses.

IVIG Safe, Effective Treating Pregnant Patients With Severe COVID-19

This combination improves patient outcomes of vaccine-induced thrombotic thrombocytopenia after a COVID-19 vaccination, according to the results of a case analysis.

Study: Start IVIG, Non-Heparin Anticoagulation Treatment Before Positive Anti-PF4 Tests

In a case study, the symptoms associated with the rash are fatigue, migratory lower extremity joint pain, and swelling of the ankles and feet.

Rare in Adults, IgA Vasculitis Presents Differently Than in Children, Analysis Shows 

MIS-C is a rare complication of SARS-CoV-2 infection, which is characterized by symptoms such as fever, multiorgan involvement, and documented SARS-CoV-2 exposure.

Study Compares Use of Corticosteroid Monotherapy, IVIG Treating Multisystem Inflammatory Syndrome in Children

Because there is an inflammatory component to Down syndrome regression disorder, it may potentially be reversible with immunotherapy.

IVIG Shows Potential to Reverse Symptoms of Down Syndrome Regression Disorder 

Recent studies that indicated the efficacy of IVIG in patients with myelin oligodendrocyte glycoprotein antibody-associated disease used pediatric cohorts, with few evaluations of the treatment approach in adults.

Maintenance IVIG Lowers Reduces Relapse in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

New validated testing method for multiple sclerosis measures kappa immunoglobulin free light chains in cerebrospinal fluid. 

Test That Measures Immunoglobulin Chains May Improve Diagnosis of MS

Nucala is an IL-5 antagonist monoclonal antibody (immunoglobulin G1 kappa) for the add-on maintenance treatment of adult and pediatric patients with severe asthma and with an eosinophilic phenotype.

Daily Medication Pearl: Mepolizumab (Nucala) 

Ramucirumab (Cyramza; Eli Lilly) is FDA-approved for 5 unique cancer indications. 

Oncology Overview: Examining the Clinical Utility of Ramucirumab Targeted Therapy 

The risk of developing acute renal failure and septic shock were higher for individuals with necrotizing soft-tissue infections treated with immunoglobulins, investigators say.

Study: IVIG Should Be Given on Case-by-Case Basis, Based on Lack of Large Trial Evidence

® IVIG Resource Center is a comprehensive resource for clinical news and expert insights on the use of intravenous immunoglobulin, a product comprised of antibodies administered intravenously.